Cargando…
No Beneficial Effect of General and Specific Anti-Inflammatory Therapies on Aortic Dilatation in Marfan Mice
AIMS: Patients with Marfan syndrome have an increased risk of life-threatening aortic complications, mostly preceded by aortic dilatation. In the FBN1 (C1039G/+) Marfan mouse model, losartan decreases aortic root dilatation. We recently confirmed this beneficial effect of losartan in adult patients...
Autores principales: | Franken, Romy, Hibender, Stijntje, den Hartog, Alexander W., Radonic, Teodora, de Vries, Carlie J. M., Zwinderman, Aeilko H., Groenink, Maarten, Mulder, Barbara J. M., de Waard, Vivian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169510/ https://www.ncbi.nlm.nih.gov/pubmed/25238161 http://dx.doi.org/10.1371/journal.pone.0107221 |
Ejemplares similares
-
Resveratrol Inhibits Aortic Root Dilatation in the Fbn1(C1039G/+) Marfan Mouse Model
por: Hibender, Stijntje, et al.
Publicado: (2016) -
The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patients–Insights from Rodent-Based Animal Studies
por: van Andel, Mitzi M., et al.
Publicado: (2019) -
The revised role of TGF-β in aortic aneurysms in Marfan syndrome
por: Franken, R., et al.
Publicado: (2014) -
Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial
por: Radonic, Teodora, et al.
Publicado: (2010) -
Aortic distensibility in Marfan syndrome: a potential predictor of aortic events?
por: van Andel, Mitzi M, et al.
Publicado: (2021)